4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-020105
Chairman and CEO bought 7,200 shares at an average $1.54 ($11,097)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-03-16 | Purchase | +1,500 | $1.58 | $2,370 | 10,488,243 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-17 | Purchase | +2,700 | $1.61 | $4,347 | 10,490,943 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-18 | Purchase | +3,000 | $1.46 | $4,380 | 10,493,943 | D |
| Open-market purchases · 7,200 sh · avg $1.54 · $11,097 | |||||||
Loading xslF345X03/doc4.xml…